Comparison of In-vitro Penetration of Transdermal Patch Containing Pure Diclofenac Sodium and Nanoparticles as Analgesic and Anti-Inflammatory

  • Zakaria Nurmalia Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sumatera  Utara, Medan, Indonesia
  • Bangun Hakim Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sumatera  Utara, Medan, Indonesia
  • Harahap Urip Department of Pharmacology, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia.

Abstract

Objective: Diclofenac sodium is a Non Steroid Anti Inflammatory class of drug which has a weakness in oral use in the form of irritation of the digestive tract. This study aims to make transdermal patches containing pure sodium diclofenac and nanoparticles with ethyl cellulose (EC) and polyvinyl pyrrolidone (PVP) polymers and compare in-vitro penetration using franz diffusion cells.


Design: This research is an experimental research which will be calculated quantitatively percent cumulative penetration of pure diclofenac sodium and nanoparticles from the transdermal patch for 8 hours.


Intervention: The variables that play a role in this research are pure diclofenac sodium and nanoparticles, both using and without enhancers


Main outcome measures: In this study, the main measurement is the absorbance value of diclofenac sodium using a spectrophotometer, which penetrates the skin on franz diffusion cells and is converted to percent cumulative penetration.


Result: Transdermal patches containing diclofenac sodium nanoparticles have a higher cumulative percent penetration (58.87 ± 0.7458%) than transdermal patches containing pure sodium diclofenac (46.6 ± 1.9438%), but not higher than transdermal patches containing pure sodium diclofenac with the addition of propylene glycol enhancers (67.59 ± 1.4675%). The three transdermal patch formulas did not differ significantly to the percent cumulative drug penetration (p> 0.05).Transdermal patches containing diclofenac sodium nanoparticles have a higher analgesic and anti-inflammatory effect than transdermal patches containing pure sodium diclofenac up to 480 minutes.


Conclusion: Transdermal patches containing sodium diclofenac nanoparticles have been shown to be able to increase drug penetration through the rabbit's stomach skin membrane in-vitro using Franz diffusion cells. Transdermal patches of pure diclofenac sodium and nanoparticles provided analgesic and anti-inflammatory effects that were significantly different from negative control.


 

Keywords: Ttransdermal patch, pure diclofenac sodium, nanoparticle diclofenac sodium, in-vitropenetration, analgesik, anti-inflammatory.

Downloads

Download data is not yet available.

Author Biographies

Zakaria Nurmalia, Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sumatera  Utara, Medan, Indonesia

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sumatera  Utara, Medan, Indonesia

Bangun Hakim, Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sumatera  Utara, Medan, Indonesia

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sumatera  Utara, Medan, Indonesia

Harahap Urip, Department of Pharmacology, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia.

Department of Pharmacology, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia.

References

1. Silva, N. H. C. S. et al. Bacterial cellulose membranes as transdermal delivery systems for diclofenac : In vitro dissolution and permeation studies. Carbohydr. Polym.2014; 106:264–269.
2. Rajabalaya, R., Khanam, J. & Nanda, A. Design of a matrix patch formulation for long-acting permeation of diclofenac potassium. Asian J. Pharm. Sci.2008; 3:30–39.
3. WHO. Chronic rheumatic conditions. World Health Organization (WHO) https://www.who.int/chp/topics/rheumatic/en/ (2019).
4. Sachan, R. & Bajpai, M. Transdermal Drug Delivery System : A Review.2013; 3:748–765.
5. Sheth, N. S. & Mistry, R. B. Formulation and evaluation of transdermal patches and to study permeation enhancement effect of eugenol. J. Appl. Pharm. Sci.2011; 01:96–101.
6. Bhowmik, D., Pusupoleti, K. R., Duraivel, S. & Kumar, K. P. S. Recent Approaches in Transdermal Drug Delivery System.2013; 2:99–108.
7. Rastogi, V., Pragya & Upadhyay, P. A Brief View On Antihypertensive Drugs Delivery Through Transdermal Patches. Int. J. Pharm. Sci. Res.2012; 3:1955–1970.
8. Taghizadeh, S. M. & Bajgholi, S. A New Liposomal-Drug-in-Adhesive Patch for Transdermal Delivery of Sodium Diclofenac. 2011; 576–581.
9. Singh, A. K., Yadav, T. P., Pandey, B., Gupta, V. & Singh, S. P. Chapter 15 - Engineering Nanomaterials for Smart Drug Release: Recent Advances and Challenges. Applications of Targeted Nano Drugs and Delivery Systems (Elsevier Inc., 2019). doi:10.1016/B978-0-12-814029-1.00015-6.
10. Sharma, M. Chapter 18 - Transdermal and Intravenous Nano Drug Delivery Systems: Present and Future. Applications of Targeted Nano Drugs and Delivery Systems (Elsevier Inc., 2019). doi:10.1016/B978-0-12-814029-1.00018-1.
11. Bibi, N., Ahmed, N. & Khan, G. M. Chapter 21 - Nanostructures in transdermal drug delivery systems. Nanostructures for Drug Delivery (Elsevier Inc., 2017). doi:10.1016/B978-0-323-46143-6/00021-X.
12. Ashok, S., Sebuah, J., Satyappa, S., Sebuah, J. & Ashok, A. Journal of Pengiriman Obat Sains dan Teknologi fabrikasi dan in-vivo evaluasi nanocarriers lipid berdasarkan transdermal patch colchicine. 2017; 41:444–453.
13. Yadav, V. Transdermal Drug Delivery System: Review. Int. J. Pharm. Sci. Res.2012; 3:376–382.
14. Muñoz, M. D., Castán, H., Ruiz, M. A. & Morales, M. E. Design, development and characterization of transdermal patch of methadone. J. Drug Deliv. Sci. Technol. (2017) doi:10.1016/j.jddst.2017.04.011.
15. Swain, R. P., Nagamani, R. & Panda, S. Formulation , in vitro Characterization and Stability Studies of Fast Dispersing Formulation , in vitro Characterization and Stability Studies of Fast Dispersing Tablets of Diclofenac Sodium. J. Appl. Pharm. Sci.2015; 5:094–102.
16. Lakhani, P., Bahl, R. & Bafna, P. Transdermal Patches: Physiochemical And In-Vitro Evaluation Methods. Int. J. Pharm. Sci. Res.2015; 6.
17. Mahajan, N. M. et al. Formulation development and evaluation of transdermal patch of piroxicam for treating dysmenorrhoea. J. Appl. Pharm. Sci.2018; 8:35–41.
18. Lintang, K., Panal, S. & Aminah, D. Asian Journal of Pharmaceutical Research and Development. Asian J. Pharm. Res. Dev.2019;7:1–5.
19. Alkilani, A. Z., Mccrudden, M. T. C. & Donnelly, R. F. Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics.2015;7:438–470 (2015).
20. Parthasarathy, G., Reddy, K. B. & Prasanth, V. V. Formulation And Characterization Of Transdermal Patches of Naproxen With Various Polymers. Pharm. Glob. Int. J. Compr. Pharm.2011; 2:1–3.
21. Walker, B. & Smith, E. W. The role of percutaneous. Adv. Drug Deliv. Rev. 1996; 295–301.
Statistics
28 Views | 9 Downloads
How to Cite
Nurmalia, Z., Hakim, B., & Urip, H. (2020). Comparison of In-vitro Penetration of Transdermal Patch Containing Pure Diclofenac Sodium and Nanoparticles as Analgesic and Anti-Inflammatory. Asian Journal of Pharmaceutical Research and Development, 8(5), 24-31. https://doi.org/https://doi.org/10.22270/ajprd.v8i5.843